GLEEVEC Safety Questions, GLEEVEC Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about GLEEVEC. Our extensive database of GLEEVEC adverse events and GLEEVEC warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about GLEEVEC
GLEEVEC Safety Reports
Total GLEEVEC reports: 1116.GLEEVEC FDA safety alerts: 2006 .
Reported deaths: 200 Reported hospitalizations: 506.
Take GLEEVEC Side Effects Survey or Share Your GLEEVEC Story. GLEEVEC Usage.
Showing 1-75 of 1116 Next >
Consumer or non-health professional from FRANCE reported GLEEVEC problem on Feb 02, 2007. Female patient, 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: arthralgia, hip arthroplasty, osteonecrosis, osteoporosis. GLEEVEC dosage: 600 MG DAILY. Patient recovered.GLEEVEC problem was reported by a Physician from UNITED STATES on Feb 01, 2007. Male patient was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: disease progression, infected insect bite. GLEEVEC dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported GLEEVEC problem on Feb 05, 2007. Male patient, 87 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: bronchiolitis. GLEEVEC dosage: unknown. Patient was hospitalized. Patient recovered.
GLEEVEC problem was reported by a Physician from FRANCE on Feb 05, 2007. Female patient, 58 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: ovarian cancer metastatic. GLEEVEC dosage: 400 MG PER DAY. Patient recovered.
Physician from BRAZIL reported GLEEVEC problem on Feb 06, 2007. Female patient, 46 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: deafness unilateral, face oedema, oedema peripheral. GLEEVEC dosage: 400 MG, QD. Patient recovered.
GLEEVEC problem was reported by a Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA on Feb 06, 2007. Male patient, 77 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, hepatic neoplasm malignant. GLEEVEC dosage: 400 MG/DAY. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from GERMANY reported GLEEVEC problem on Feb 05, 2007. Female patient, 66 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cholecystectomy, gamma-glutamyltransferase increased, lipase increased, transaminases increased. GLEEVEC dosage: 300 MG/DAY. Patient was hospitalized. Patient recovered.
GLEEVEC problem was reported by a Physician from KOREA, REPUBLIC OF on Feb 15, 2007. Male patient, 56 years of age, weighting 123.2 lb, was diagnosed with acute lymphocytic leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: pyrexia, septic shock. GLEEVEC dosage: 600 MG, QD. During the same period patient was treated with VINCRISTINE, DAUNORUBICIN, PREDNISOLONE. Patient was hospitalized. Patient recovered.
Physician from RUSSIAN FEDERATION reported GLEEVEC problem on Jan 31, 2007. Female patient, 29 years of age, was diagnosed with chronic myeloid leukaemia, post procedural hypothyroidism and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: abortion induced, foetal growth retardation. GLEEVEC dosage: 400 MG, QD. During the same period patient was treated with LEVOTHYROXINE. Patient recovered.
GLEEVEC problem was reported by a Physician from PHILIPPINES on Feb 07, 2007. Male patient, 56 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: albuminuria, blood creatinine increased, haematuria, haemorrhage. GLEEVEC dosage: 400 MG, QD. During the same period patient was treated with NEOBLOC, PERINDOPRIL ERBUMINE, FORTIFER, GLUCOVANCE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported GLEEVEC problem on Feb 20, 2007. Female patient, 65 years of age, was diagnosed with glioblastoma multiforme and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: aphasia, convulsion, disease progression, mental status changes, nuclear magnetic resonance imaging brain abnormal. GLEEVEC dosage: 400 MG QD. During the same period patient was treated with HYDROXYUREA, TOPROL, DECADRON, PEPCID, DILANTIN, LOVENOX, LEXAPRO. Patient was hospitalized. Patient recovered.
GLEEVEC problem was reported by a Consumer or non-health professional from FRANCE on Feb 16, 2007. Female patient, 77 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: lip and/or oral cavity cancer, squamous cell carcinoma. GLEEVEC dosage: 400 MG, QD. Patient recovered.
Consumer or non-health professional from FRANCE reported GLEEVEC problem on Feb 16, 2007. Female patient, 77 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: lip and/or oral cavity cancer, squamous cell carcinoma, stomatitis. GLEEVEC dosage: 400 MG, QD. Patient recovered.
GLEEVEC problem was reported by a Physician from GERMANY on Feb 16, 2007. Female patient, 78 years of age, weighting 130.1 lb, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: cachexia, cholestasis, pancreatic carcinoma. GLEEVEC dosage: 400 MG, QD. Patient died on 12/07/2006.
Physician from NETHERLANDS reported GLEEVEC problem on Feb 09, 2007. Male patient, 66 years of age, was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: erectile dysfunction, organic erectile dysfunction. GLEEVEC dosage: 400 MG, QD. Patient recovered.
GLEEVEC problem was reported by a Physician from SOUTH AFRICA on Feb 08, 2007. Female patient, 19 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: dyspnoea, haemothorax, neutrophil count, respiratory distress, thoracic cavity drainage. GLEEVEC dosage: 400 MG, QD. During the same period patient was treated with HYDROXYUREA. Patient was hospitalized. Patient recovered.
Pharmacist from JAPAN reported GLEEVEC problem on Feb 09, 2007. Male patient was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: arthralgia, muscle rupture. GLEEVEC dosage: 300 MG/DAY. Patient recovered.
GLEEVEC problem was reported by a Physician from UNITED STATES on Feb 09, 2007. Male patient, 62 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: chronic myeloid leukaemia, disease progression, infected insect bite. GLEEVEC dosage: 600 MG, QD. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported GLEEVEC problem on Feb 09, 2007. Female patient was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: osteonecrosis, rhabdomyolysis. GLEEVEC dosage: 400 MG, QD. During the same period patient was treated with CHOLESTEROL. Patient was hospitalized. Patient recovered.
GLEEVEC problem was reported by a Physician from UNITED STATES on Feb 21, 2007. Male patient, 58 years of age, weighting 213.8 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: leukopenia, rash. GLEEVEC dosage: 600 MG PO. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported GLEEVEC problem on Feb 21, 2007. Male patient was diagnosed with gastrointestinal cancer metastatic and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: bradycardia, gastrointestinal haemorrhage, haematemesis, haemoglobin decreased, procedural complication, procedural hypotension, rectal haemorrhage, syncope. GLEEVEC dosage: 600 MG ONCE DAILY PO. Patient was hospitalized. Patient recovered.
GLEEVEC problem was reported by a Pharmacist from UNITED STATES on Feb 21, 2007. Male patient, weighting 210.0 lb, was diagnosed with acute myeloid leukaemia, chromosome analysis abnormal and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, haemodialysis, urine output decreased. GLEEVEC dosage: 400 MG BID PO. Patient was hospitalized and became disabled. Patient recovered.
Consumer or non-health professional from UNITED STATES reported GLEEVEC problem on Feb 12, 2007. Male patient, 29 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: arthralgia, bone infarction. GLEEVEC dosage: 400 MG, QD. During the same period patient was treated with SEROQUEL, TOPAMAX, FENTANYL. Patient recovered.
GLEEVEC problem was reported by a Physician from FRANCE on Feb 14, 2007. Female patient, 77 years of age, weighting 172.0 lb, was diagnosed with gastrointestinal stromal tumour, diabetes mellitus non-insulin-dependent, hypertension, oedema and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. GLEEVEC dosage: 400 MG DAILY. During the same period patient was treated with DIAMICRON, MODUCREN, DIOSMINE. Patient was hospitalized. Patient recovered.
Physician from PHILIPPINES reported GLEEVEC problem on Feb 07, 2007. Male patient, 56 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: albuminuria, blood creatinine increased, haematuria, haemorrhage. GLEEVEC dosage: 400 MG, QD. During the same period patient was treated with NEOBLOC, PERINDOPRIL ERBUMINE, FORTIFER, GLUCOVANCE. Patient was hospitalized. Patient recovered.
GLEEVEC problem was reported by a Physician from RUSSIAN FEDERATION on Jan 31, 2007. Female patient, 29 years of age, was diagnosed with chronic myeloid leukaemia, post procedural hypothyroidism and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: abortion induced, foetal growth retardation. GLEEVEC dosage: 400 MG, QD. During the same period patient was treated with LEVOTHYROXINE. Patient recovered.
Physician from KOREA, REPUBLIC OF reported GLEEVEC problem on Feb 15, 2007. Male patient, 56 years of age, weighting 123.2 lb, was diagnosed with acute lymphocytic leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: pyrexia, septic shock. GLEEVEC dosage: 600 MG, QD. During the same period patient was treated with VINCRISTINE, DAUNORUBICIN, PREDNISOLONE. Patient was hospitalized. Patient recovered.
GLEEVEC problem was reported by a Health Professional from UNITED STATES on Feb 26, 2007. Male patient was diagnosed with prostate cancer and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: disease progression, pain, refusal of treatment by patient, spinal compression fracture. GLEEVEC dosage: 300 MG QD PO. During the same period patient was treated with SORAFENIB. Patient was hospitalized. Patient died on 02/22/2007.
Physician from GERMANY reported GLEEVEC problem on Feb 15, 2007. Male patient was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: visual acuity reduced. GLEEVEC dosage: 400 MG, QD. Patient recovered.
GLEEVEC problem was reported by a Physician from SPAIN on Feb 15, 2007. Female patient, 66 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: articular calcification, calcification of muscle, tendon calcification. GLEEVEC dosage: 400 MG/DAY. Patient recovered.
Physician from GERMANY reported GLEEVEC problem on Feb 15, 2007. Female patient was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, cardiac failure, ejection fraction decreased, pleural effusion. GLEEVEC dosage: 400 MG, QD. Patient was hospitalized. Patient recovered.
GLEEVEC problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 16, 2007. Female patient, 40 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, constipation, diarrhoea, diastolic hypotension, dizziness, tachyarrhythmia, vomiting. GLEEVEC dosage: 400 MG, QD. Patient recovered.
Physician from ITALY reported GLEEVEC problem on Feb 15, 2007. Male patient, 75 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: arthralgia, osteonecrosis, prostate cancer, prostatic operation. GLEEVEC dosage: 400 MG/DAY. Patient recovered.
GLEEVEC problem was reported by a Consumer or non-health professional from JAPAN on Feb 23, 2007. Male patient, 31 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: blast crisis in myelogenous leukaemia, graft versus host disease, sepsis, stem cell transplant. GLEEVEC dosage: 400 MG/DAY. Patient was hospitalized. Patient died on 08/01/2005.
Physician from SWITZERLAND reported GLEEVEC problem on Feb 16, 2007. Female patient was diagnosed with chronic myeloid leukaemia, anaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: hearing impaired. GLEEVEC dosage: 600 MG/DAY. During the same period patient was treated with FOLVITE, VITAMIN B. Patient recovered.
GLEEVEC problem was reported by a Physician from FRANCE on Feb 16, 2007. Female patient, 58 years of age, weighting 121.3 lb, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: metastases to liver, metastases to peritoneum, ovarian cancer metastatic. GLEEVEC dosage: 400 MG PER DAY. Patient recovered.
Physician from SWITZERLAND reported GLEEVEC problem on Feb 20, 2007. Male patient, 36 years of age, weighting 224.9 lb, was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: arthralgia, chondropathy, meniscus lesion, muscle spasms, myalgia. GLEEVEC dosage: 400 MG/DAY. During the same period patient was treated with ALLOPURINOL. Patient recovered.
GLEEVEC problem was reported by a Pharmacist from UNITED KINGDOM on Feb 20, 2007. Male patient was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: erythema nodosum, no therapeutic response. GLEEVEC dosage: 600 MG, QD. Patient recovered.
Health Professional from UNITED KINGDOM reported GLEEVEC problem on Mar 01, 2007. Male patient, 58 years of age, weighting 207.0 lb, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis coronary artery, circulatory collapse, left ventricular failure, vomiting. GLEEVEC dosage: 600MG/DAY. Patient was hospitalized. Patient died on 12/10/2006.
GLEEVEC problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 21, 2007. Female patient, 69 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, contusion, eyelid oedema, oedema peripheral, rash. GLEEVEC dosage: 400 MG, QD. Patient was hospitalized. Patient recovered.
Health Professional from ITALY reported GLEEVEC problem on Feb 28, 2007. Male patient, 50 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: asthenia, blast cells present, blast crisis in myelogenous leukaemia, cerebral haemorrhage, disseminated intravascular coagulation, haemoglobin decreased, platelet count decreased, white blood cell count decreased. GLEEVEC dosage: 400 MG/D. Patient died.
GLEEVEC problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2007. Male patient, 76 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain, chills, diarrhoea, dizziness, flatulence, headache, nuclear magnetic resonance imaging abnormal, oedema peripheral. GLEEVEC dosage: 400 MG, QD. During the same period patient was treated with DIOVAN, LIPITOR, LASIX, ATENOLOL, HYDROCODONE. Patient recovered.
Physician from SPAIN reported GLEEVEC problem on Feb 23, 2007. Male patient, 74 years of age, was diagnosed with chronic myeloid leukaemia, anxiety and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: cardiac failure, escherichia urinary tract infection, hypertensive cardiomyopathy, respiratory tract infection. GLEEVEC dosage: 400 MG, QD. During the same period patient was treated with FUROSEMIDE, CAPTOPRIL, OMEPRAZOLE, ALOPURINOL, METAMIZOLE, ALPRAZOLAM, PIRACETAM, RAMIPRIL. Patient was hospitalized. Patient recovered.
GLEEVEC problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 26, 2007. Male patient, 79 years of age, weighting 169.0 lb, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: amnesia, asthenia, confusional state, dementia alzheimer's type, diarrhoea, disorientation, haematochezia, mental status changes. GLEEVEC dosage: unknown. During the same period patient was treated with COREG, ALLOPURINOL, FLOMAX, DIGITEK. Patient recovered.
Physician from FRANCE reported GLEEVEC problem on Mar 02, 2007. Male patient, 79 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: rectosigmoid cancer, surgery. GLEEVEC dosage: 400 MG PER DAY. Patient recovered.
GLEEVEC problem was reported by a Physician from UNITED STATES on Feb 27, 2007. Female patient, 20 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: cervical dysplasia. GLEEVEC dosage: 400 MG, QD. Patient recovered.
Physician from UNITED STATES reported GLEEVEC problem on Feb 26, 2007. Female patient, 50 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: eye inflammation, uveitis. GLEEVEC dosage: 400 MG, QD. During the same period patient was treated with ALLEGRA, ZYRTEC, ATENOLOL, ESTRACE, VITAMIN CAP, CALTRATE. Patient recovered.
GLEEVEC problem was reported by a Health Professional from ECUADOR on Feb 26, 2007. Male patient, 50 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: arthralgia, conjunctival hyperaemia, dry mouth, dry skin, eyelid oedema, face oedema, fatigue, muscle spasms, muscular weakness. GLEEVEC dosage: 600 MG, QD. Patient recovered.
Physician from SPAIN reported GLEEVEC problem on Feb 27, 2007. Female patient, 68 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: colon cancer metastatic, colon cancer stage iv. GLEEVEC dosage: unknown. Patient recovered.
GLEEVEC problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 26, 2007. Male patient, 79 years of age, weighting 169.0 lb, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: amnesia, asthenia, confusional state, dementia alzheimer's type, diarrhoea, disorientation, haematochezia, mental status changes. GLEEVEC dosage: unknown. During the same period patient was treated with COREG, ALLOPURINOL, FLOMAX, DIGITEK. Patient recovered.
Physician from SPAIN reported GLEEVEC problem on Mar 01, 2007. Female patient, 47 years of age, was diagnosed with chronic myeloid leukaemia, anxiety and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: anxiety, diarrhoea, headache, hyperreflexia, hypokalaemia, tremor, weight decreased. GLEEVEC dosage: 400 MG/D. During the same period patient was treated with ZOLPIDEM, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
GLEEVEC problem was reported by a Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA on Mar 07, 2007. Female patient, 24 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: haemorrhagic ovarian cyst. GLEEVEC dosage: unknown. Patient recovered.
Physician from reported GLEEVEC problem on Mar 02, 2007. Male patient, 75 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: myocardial infarction, plasmacytoma, surgery. GLEEVEC dosage: 300 MG DAILY. Patient recovered.
GLEEVEC problem was reported by a Physician from PHILIPPINES on Mar 05, 2007. Male patient, 56 years of age, weighting 157.9 lb, was diagnosed with gastrointestinal stromal tumour, arrhythmia, anaemia, diabetes mellitus and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: albuminuria, anaemia, blood creatinine increased, haematuria, melaena, nephrolithiasis, upper gastrointestinal haemorrhage. GLEEVEC dosage: 400 MG, QD. During the same period patient was treated with NEOBLOC, PERINDOPRIL ERBUMINE, FORTIFER, GLUCOVANCE. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported GLEEVEC problem on Mar 14, 2007. Male patient, 67 years of age, weighting 222.7 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: anaemia, cardiomegaly, dyspnoea, platelet count decreased, pneumonia, pulmonary vascular disorder, pyrexia, supraventricular extrasystoles, ventricular hypertrophy. GLEEVEC dosage: 600 MG PO. Patient was hospitalized. Patient recovered.
GLEEVEC problem was reported by a Physician from UNITED STATES on Mar 06, 2007. Male patient, 40 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: dizziness, dysphonia, gait disturbance, multiple sclerosis, muscular weakness, paraesthesia. GLEEVEC dosage: 400 MG, QD. Patient was hospitalized. Patient recovered.
Physician from CHINA reported GLEEVEC problem on Mar 06, 2007. Female patient was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: blast cells present, lung infection, lymphadenopathy, pyrexia, white blood cell count increased. GLEEVEC dosage: 400 MG, QD. Patient recovered.
GLEEVEC problem was reported by a Consumer or non-health professional from GERMANY on Mar 06, 2007. Female patient was diagnosed with chronic myeloid leukaemia, hypertension and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: rash, swelling face, thrombocythaemia. GLEEVEC dosage: 200 MG/DAY. During the same period patient was treated with RAMIPRIL, BLOPRESS PLUS. Patient recovered.
Physician from RUSSIAN FEDERATION reported GLEEVEC problem on Mar 13, 2007. Male patient, 70 years of age, was diagnosed with chronic myeloid leukaemia, anaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: gastric cancer, haemoglobin decreased, myocardial infarction, tumour haemorrhage. GLEEVEC dosage: 400 MG/DAY. During the same period patient was treated with SORBIFER DURULES, RECORMON. Patient died on 02/14/2007.
GLEEVEC problem was reported by a Physician from FRANCE on Mar 02, 2007. Female patient, 69 years of age, weighting 121.3 lb, was diagnosed with chronic myeloid leukaemia, lung neoplasm malignant and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: bronchitis, conjunctival haemorrhage, dehydration, diarrhoea, erythema, gastric disorder, leukocytosis, lung neoplasm malignant. GLEEVEC dosage: 400 MG DAILY. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported GLEEVEC problem on Mar 16, 2007. Female patient, 37 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: eye haemorrhage, vitrectomy. GLEEVEC dosage: 400 MG, QD. Patient recovered.
GLEEVEC problem was reported by a Consumer or non-health professional from JAPAN on Mar 13, 2007. Female patient, child 8 years of age, was diagnosed with acute lymphocytic leukaemia recurrent and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: aspergillosis, blood beta-d-glucan increased, bronchopulmonary aspergillosis, cough, malignant neoplasm progression, multi-organ failure, neutropenia, pyrexia. GLEEVEC dosage: unknown. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE, CYTARABINE, IDARUBICIN, IFOSFAMIDE, FLUCONAZOLE, MICAFUNGIN. Patient died.
Health Professional from UNITED STATES reported GLEEVEC problem on Mar 20, 2007. Female patient, weighting 100.1 lb, was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: conjunctival haemorrhage, disseminated intravascular coagulation. GLEEVEC dosage: 9600 MG. Patient recovered.
GLEEVEC problem was reported by a Physician from SPAIN on Mar 09, 2007. Female patient, 66 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: articular calcification, calcification of muscle, tendon calcification. GLEEVEC dosage: 400 MG/DAY. Patient recovered.
Consumer or non-health professional from UNITED STATES reported GLEEVEC problem on Mar 09, 2007. Male patient, 60 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: alcoholism, amnesia, convulsion, depressed level of consciousness, laceration, loss of consciousness, mouth haemorrhage, musculoskeletal disorder. GLEEVEC dosage: unknown. During the same period patient was treated with ALCOHOL. Patient was hospitalized. Patient recovered.
GLEEVEC problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 09, 2007. Female patient, 31 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: chromosome analysis abnormal, multiple pregnancy. GLEEVEC dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from SLOVENIA reported GLEEVEC problem on Mar 14, 2007. Female patient, 33 years of age, weighting 136.7 lb, was diagnosed with gastrointestinal stromal tumour and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, chest x-ray abnormal, computerised tomogram abnormal, confusional state, cough, gamma-glutamyltransferase increased. GLEEVEC dosage: 400 MG, QD. Patient died on 12/26/2006.
GLEEVEC problem was reported by a Physician from NETHERLANDS on Mar 12, 2007. Female patient, 81 years of age, weighting 110.2 lb, was diagnosed with gastrointestinal stromal tumour and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: bleeding time prolonged, glaucoma, visual disturbance. GLEEVEC dosage: 400 MG/DAY. Patient recovered.
Physician from JAPAN reported GLEEVEC problem on Mar 12, 2007. Male patient, 87 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: bronchiolitis, dyspnoea, pyrexia. GLEEVEC dosage: 200 MG/D. During the same period patient was treated with FAMOTIDINE, MUCOSTA, ASPIRIN, LASIX, CLEANAL, URALYT. Patient was hospitalized. Patient recovered.
GLEEVEC problem was reported by a Physician from UNITED STATES on Mar 12, 2007. Female patient was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, osteonecrosis, rhabdomyolysis. GLEEVEC dosage: 400 MG, QD. During the same period patient was treated with CHOLESTEROL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported GLEEVEC problem on Mar 13, 2007. Male patient, 76 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: artificial crown procedure, bone formation decreased, gingival pain, impaired healing, sensitivity of teeth, tooth abscess, tooth extraction. GLEEVEC dosage: 400 MG, QD. Patient recovered.
GLEEVEC problem was reported by a Physician from UNITED KINGDOM on Mar 13, 2007. Male patient, 24 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: ejaculation failure, erectile dysfunction, gynaecomastia, hypogonadism male, testicular disorder. GLEEVEC dosage: unknown. Patient recovered.
Physician from FRANCE reported GLEEVEC problem on Mar 15, 2007. Female patient was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: metastases to bone, metastases to liver. GLEEVEC dosage: unknown. Patient was hospitalized. Patient recovered.
GLEEVEC problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2007. Female patient, 54 years of age, weighting 141.1 lb, was diagnosed with chronic myeloid leukaemia, osteoporosis and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: anaemia, arthralgia, bladder cancer, bladder neoplasm surgery, decreased appetite, diarrhoea, dry mouth, gastrointestinal disorder, gravitational oedema. GLEEVEC dosage: 400 MG, QD. During the same period patient was treated with ACTONEL, CALCIUM. Patient recovered.
Pharmacist from JAPAN reported GLEEVEC problem on Mar 14, 2007. Female patient, 76 years of age, weighting 99.21 lb, was diagnosed with chronic myeloid leukaemia, constipation, prophylaxis and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: dry skin, eczema asteatotic, gastric cancer, hepatic failure, hepatitis b, liver disorder, pancytopenia, pyrexia, rash. GLEEVEC dosage: 200 MG/DAY. During the same period patient was treated with MAGNESIUM OXIDE HEAVY, MUCOSOLVAN, LAC B, HYDREA, CYMERIN, PREDONINE. Patient was hospitalized. Patient recovered.
Showing 1-75 of 1116 Next >
This
drug has an active FDA Safety Alert